Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S Cartwright

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|September 4, 2004
Cocaine medications, cocaine consumption and societal costsW S Cartwright
Evaluation Review|September 4, 1998
Cost-benefit and cost-effectiveness analysis of drug abuse treatment servicesW S Cartwright
Health Care Financing Review|December 4, 1993
A patient-based analysis of drug disorder diagnoses in the Medicare populationW S Cartwright, L M Ingster
The American Journal of Drug and Alcohol Abuse|February 1, 1995
Drug disorders and cardiovascular disease: the impact on annual hospital length of stay for the Medicare populationL M Ingster, W S Cartwright
NIDA Research Monograph|January 1, 1991
Health insurance coverage questions, public health surveys, and drug abuseW S Cartwright, A M Woodward
The Gerontologist|April 1, 1986
Evaluation of the costs of caring for the senile demented elderly: a pilot studyT W Hu, L F Huang, W S Cartwright
Public Health Reports (Washington, D.C. : 1974)|January 1, 1988
The economic cost of senile dementia in the United States, 1985L F Huang, W S Cartwright, T W Hu
Journal of Substance Abuse Treatment|June 20, 1998
Service-level costing of drug abuse treatmentD W Anderson, B J Bowland, W S Cartwright, et al.
Annual Review of Gerontology & Geriatrics|January 1, 1986
Geriatric epidemiologyL R White, W S Cartwright, J Cornoni-Huntley, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|September 4, 2004
Cocaine medications, cocaine consumption and societal costsW S Cartwright
Evaluation Review|September 4, 1998
Cost-benefit and cost-effectiveness analysis of drug abuse treatment servicesW S Cartwright
Health Care Financing Review|December 4, 1993
A patient-based analysis of drug disorder diagnoses in the Medicare populationW S Cartwright, L M Ingster
The American Journal of Drug and Alcohol Abuse|February 1, 1995
Drug disorders and cardiovascular disease: the impact on annual hospital length of stay for the Medicare populationL M Ingster, W S Cartwright
NIDA Research Monograph|January 1, 1991
Health insurance coverage questions, public health surveys, and drug abuseW S Cartwright, A M Woodward
The Gerontologist|April 1, 1986
Evaluation of the costs of caring for the senile demented elderly: a pilot studyT W Hu, L F Huang, W S Cartwright
Public Health Reports (Washington, D.C. : 1974)|January 1, 1988
The economic cost of senile dementia in the United States, 1985L F Huang, W S Cartwright, T W Hu
Journal of Substance Abuse Treatment|June 20, 1998
Service-level costing of drug abuse treatmentD W Anderson, B J Bowland, W S Cartwright, et al.
Annual Review of Gerontology & Geriatrics|January 1, 1986
Geriatric epidemiologyL R White, W S Cartwright, J Cornoni-Huntley, et al.
Pageof 1